Session Datesort descending
The Use of Stereotactic Radiosurgery to Treat Functional Disorders: A Topic Discussion, January 9th, 2024 01/09/2024 - 8:00am to 9:00am CST
SBRT in Oligoprogressive Breast or Non-small Cell Lung Cancer - CURB -2/5/24 02/05/2024 - 8:00am to 9:00pm CST
Hodgkin Lymphoma and the role of RT: Long-term Outcomes from H10, March 4th, 2024 03/04/2024 - 8:00am to 9:00am CST
Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms. The NRG-GU003 Phase 3 Randomized Clinical Trial, March 29, 2024 03/29/2024 - 8:00am to 9:00pm CDT
Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial, May 14th, 2024 05/14/2024 - 8:00am to 9:00am CDT
Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma, June 19,, 2024 06/19/2024 - 8:00am to 9:00pm CDT
Stereotactic Ablative Radiotherapy for T1 to T2 Glottic Larynx Cancer: Mature Results from the Phase 2 GLoTtic Larynx-SABR Trial, Nov. 4th, 2024 11/04/2024 - 8:00am to 9:00pm CST
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma, Dec. 2nd, 2024 12/02/2024 - 8:00am to 9:00pm CST
Human Oncology Journal Club (2024) - Planning Committee Disclosure 02/28/2025 - 11:00pm to 11:59pm CST